N-Nitroso Edoxaban Impurity 4
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Edoxaban is used to prevent stroke and blood clots in patients with a certain heart rhythm problem (eg, nonvalvular atrial fibrillation). Edoxaban is also used to treat deep venous thrombosis, a condition in which harmful blood clots form in the blood vessels of the legs .N-Nitroso Edoxaban Impurity 4 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Edoxaban Impurity 4 chemically represented as 2-bromo-5-nitroso-4,5,6,7- tetrahydrothiazolo[5,4-c] pyridine . Synchemia is the leading manufacturing and exporter of N-Nitroso Edoxaban Impurity 4 .We supply N-Nitroso Edoxaban Impurity 4 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-E39225 |
| CAS No | NA |
| Mol.F. | C24H26Cl2N6O5 |
| Mol.Wt. | 549.4g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39226 |
| CAS No | 929693-31-2 |
| Mol.F. | C15H28N2O6S |
| Mol.Wt. | 364.5g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39227 |
| CAS No | NA |
| Mol.F. | C9H14N2O3 |
| Mol.Wt. | 198.2g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39228 |
| CAS No | NA |
| Mol.F. | C9H14N2O3 |
| Mol.Wt. | 198.2g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39229 |
| CAS No | NA |
| Mol.F. | C20H29N5O5S |
| Mol.Wt. | 451.5g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39230 |
| CAS No | NA |
| Mol.F. | C16H22ClN5O3 |
| Mol.Wt. | 367.8g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39231 |
| CAS No | NA |
| Mol.F. | C23H25Cl2N7O5 |
| Mol.Wt. | 550.4g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39232 |
| CAS No | NA |
| Mol.F. | C24H32ClN7O4S |
| Mol.Wt. | 550.1g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39233 |
| CAS No | 41374-72-5 |
| Mol.F. | C9H10N2O3 |
| Mol.Wt. | 194.2g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39234 |
| CAS No | NA |
| Mol.F. | C18H24ClN5O4 |
| Mol.Wt. | 409.9g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39235 |
| CAS No | 480449-84-1 |
| Mol.F. | C14H26N2O4 |
| Mol.Wt. | 286.4g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39236 |
| CAS No | 2111181-37-2 |
| Mol.F. | C14H24N2O4 |
| Mol.Wt. | 284.4g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39237 |
| CAS No | NA |
| Mol.F. | C14H27N3O3 |
| Mol.Wt. | 285.4g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39238 |
| CAS No | NA |
| Mol.F. | C14H27N3O3 |
| Mol.Wt. | 285.4g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39239 |
| CAS No | 2230882-27-4 |
| Mol.F. | C14H27N3O3 |
| Mol.Wt. | 285.4g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39240 |
| CAS No | 1255529-34-0 |
| Mol.F. | C14H27N3O3 |
| Mol.Wt. | 285.4g/mole |
| INV STATUS | CUSTOM SYNTHESIS |